Monocytes are resistant to apoptosis in systemic juvenile idiopathic arthritis

被引:20
|
作者
Srivastava, Shivani [2 ]
Macaubas, Claudia
Deshpande, Chetan
Alexander, Heather C. [3 ]
Chang, Sheng-Yung [3 ]
Sun, Yue
Park, Jane L. [4 ]
Lee, Tzielan [4 ]
Begovich, Ann [3 ]
Mellins, Elizabeth D. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Pediat, Program Immunol, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Biol, Stanford, CA 94305 USA
[3] Celera, Alameda, CA USA
[4] Stanford Univ, Dept Pediat, Div Pediat Rheumatol, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
Systemic juvenile arthritis; Monocytes; Apoptosis; MIGRATION INHIBITORY FACTOR; MACROPHAGE ACTIVATION SYNDROME; TUMOR-NECROSIS-FACTOR; CELL-DEATH APOPTOSIS; RHEUMATOID-ARTHRITIS; PERIPHERAL-BLOOD; FAS LIGAND; GENE-EXPRESSION; ALVEOLAR MACROPHAGES; CASPASE-8; ACTIVATION;
D O I
10.1016/j.clim.2010.04.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated whether circulating monocytes from patients with systemic juvenile idiopathic arthritis (SJIA) are resistant to apoptosis and which apoptotic pathway(s) may mediate this resistance. A microarray analysis of peripheral blood mononuclear cells (PBMC) of SJIA samples and RT-PCR analysis of isolated monocytes showed that monocytes from active SJIA patients express transcripts that imply resistance to apoptosis. SJIA monocytes incubated in low serum show reduced annexin binding and diminished FasL up-regulation compared to controls. SJIA monocytes are less susceptible to anti-Fas-induced apoptosis and, upon activation of the mitochondrial pathway with staurosporine, show diminished Bid cleavage and Bcl-w down-regulation compared to controls. Exposure to SJIA plasma reduces responses to apoptotic triggers in normal monocytes. Thus, SJIA monocytes are resistant to apoptosis due to alterations in both the extrinsic and intrinsic apoptosis pathways, and circulating factors associated with active SJIA may confer this phenotype. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:257 / 268
页数:12
相关论文
共 50 条
  • [21] Comparison of biomarkers for systemic juvenile idiopathic arthritis
    Susan Shenoi
    Jing-Ni Ou
    Chester Ni
    Claudia Macaubas
    Vivian H Gersuk
    Carol A Wallace
    Elizabeth D Mellins
    Anne M Stevens
    Pediatric Research, 2015, 78 : 554 - 559
  • [22] Comparison of biomarkers for systemic juvenile idiopathic arthritis
    Shenoi, Susan
    Ou, Jing-Ni
    Ni, Chester
    Macaubass, Claudia
    Gersuk, Vivian H.
    Wallace, Carol A.
    Mellins, Elizabeth D.
    Stevens, Anne M.
    PEDIATRIC RESEARCH, 2015, 78 (05) : 554 - 559
  • [24] Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
    Murakami, Miho
    Tomiita, Minako
    Nishimoto, Norihiro
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2012, 4 : 71 - 79
  • [25] Systemic-onset juvenile idiopathic arthritis
    Cimaz, Rolando
    AUTOIMMUNITY REVIEWS, 2016, 15 (09) : 931 - 934
  • [26] Glucose metabolism in systemic juvenile idiopathic arthritis
    Papatsorn Suppasit
    Soamarat Vilaiyuk
    Preamrudee Poomthavorn
    Sarunyu Pongratanakul
    Patcharin Khlairit
    Pat Mahachoklertwattana
    Pediatric Rheumatology, 20
  • [27] Thalidomide for systemic onset juvenile idiopathic arthritis
    Sathe, K.
    Khubchandani, R. P.
    INDIAN PEDIATRICS, 2013, 50 (02) : 237 - 242
  • [28] Treatment Options for the systemic juvenile idiopathic Arthritis
    不详
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2010, 69 (09): : 849 - 849
  • [29] Monocyte phenotypes in systemic juvenile idiopathic arthritis
    Macaubas, Claudia
    Khoa Nguyen
    Peck, Ariana
    Wong, Elizabeth
    Buckingham, Julia
    Goertz, Yael
    Deshpande, Chetan
    Alexander, Heather
    Chang, Sheng-Yung
    Sun, Yue
    Park, Jane
    Lee, Tzielan
    Begovich, Ann
    Mellins, Elizabeth
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [30] Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis
    Nigrovic, Peter A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (52) : 15785 - 15786